热门资讯> 正文
立体声合成在欧盟的MDR监管框架下获得CE标志重新认证
2024-05-24 20:58
- Stereotaxis (NYSE:STXS) on Friday announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation regulatory framework.
- The recertification under MDR covers all Stereotaxis devices currently available in Europe.
- Source: Press Release
More on Stereotaxis
- Stereotaxis Makes A Strategic Acquisition Bolstering Its Future
- Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months
- Stereotaxis Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Stereotaxis
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
